BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23992112)

  • 1. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia.
    Nielsen T; Nielsen NC; Holm TH; Ostergaard L; Horsman MR; Busk M
    Acta Oncol; 2013 Oct; 52(7):1287-92. PubMed ID: 23992112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
    Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
    Weidensteiner C; Rausch M; McSheehy PM; Allegrini PR
    J Magn Reson Imaging; 2006 Sep; 24(3):646-56. PubMed ID: 16878308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK
    Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation of heterogeneous molecular delivery in tumours using μCT reconstructions and MRI validation.
    Wittenborn TR; Nielsen T; Thomsen JS; Horsman MR; Nygaard JV
    Microvasc Res; 2016 Nov; 108():69-74. PubMed ID: 27569845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.
    Wang C; Subashi E; Yin FF; Chang Z
    Med Phys; 2016 Mar; 43(3):1335-47. PubMed ID: 26936718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T.
    Yankeelov TE; DeBusk LM; Billheimer DD; Luci JJ; Lin PC; Price RR; Gore JC
    J Magn Reson Imaging; 2006 Nov; 24(5):1140-7. PubMed ID: 17024660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
    Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
    J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
    Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
    J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.